click below
click below
Normal Size Small Size show me how
HIV
| Question | Answer |
|---|---|
| General characteristics of HIV | Retroviridae Lentivirus genus HIV-1 99% cases in europe & USA HIV-2 mainly west Africa HIV-1 and HIV-2 40% homology HIV-1 3 phylogenetic clades, M N O. MAIN NON-MAIN and OUTLIER. Majority of subtypes in main group |
| Epidemiology | Infection with HIV-1 - AIDS 1.8 million deaths, 27-60 million people affected worldwide |
| Pathogenesis | AIDS- complex of signs and symptoms associated with HIV, characterised by the presence of rare and opportunistic pathogens in the presence of anti-HIV antibodies. |
| Transmission | Unprotected sex Mother to child transmission (verticle, in utero, during delivery, in breastmilk) IV drug use |
| Infection pattern | Initial contact - virus infects dendritic cells at muscosal surface before infecting CD4+ T cells. These T cells become activated facilitating release and spread of virus. Reservoirs established in lymphoid tissue (GALT LN) |
| Infection pattern cont. | Years later Cd8+ cells respond - already chronic HIV production. Adaptive immune response reduces HIV levels dramatically, CD4+ cells destroyed over 5-10 years, HIV levels rise and opportunistic pathogens infect |
| Particle and genome structure | 2 copies of +ve sense ssRNA genome enclosed by cone shaped capsid surrounded by host derived lipid envelope 9.7kb genome 9 genes encoding 16 proteins |
| LTR | Contains control region which bind transcription factors initiating transcription |
| gag | polyprotein processed into matrix, capsid, nucleocapsid and a budding protein |
| pol | encodes viral enzymes which process other HIV genes, includes RT |
| env | produces gp160 protein which is cleaved into gp120 and gp41. gp120 - CD4 and co-receptor binding, gp41 - mediates fusion |
| VPR | facilitates infection of macrophages |
| VPU | promotes CD4 degredation allowing viral release from cell (similar to neuraminidase) |
| Vif | overcomes unknown cellular inhibitory effects |
| Nef | promotes CD4 and MHC1 downregulation, blocks apoptosis, enhances viral infectivitiy, alters state of cellular activation |
| Rev | regulates viral gene expression through deactivation viral splicing machinery allowing incomplete spliced transcripts |
| tat | enhances RNA pol II, binds to LTR |
| Receptors | CCR5 - Macrophages CXCR4 - T helper cells |
| Mechanisms of HIV killing | Formation of giant cells with multiple nuclei through interaction with gp120, gp41 and CD4 + co-receptors Accumulation of unintegrated forms of linear viral DNA Proapoptotic effects of Tat, nef and VPR Metabolic burden of HIV replication |
| Mechanisms of HIV killing 2. | Expression of nef alone as a transgene in mice confers loss of immunity and death of CD4+ cells |
| Disease progression | Can be acute (2-5 years) slow (long term non progression (5-10 years) elite controllers (20 year+) |
| Disease progresssion 2. | Viral factors: virus copy number and set point (stable viral load within an individual) virus fitness (rapid changing of genome, fitness can be advantageous or disadvantageous e.g increased expression of Nef) Host - 32bp deletion in CCR5- HIV reduction |
| Patient treatment and antivirals | CD4+ <200 patients started on HAART (highly activate antiretrovial therapy) targets - RT, HIV proviral DNA, integrase, protease, TAT antagonists. targets identifed by producing double negative mutants - found TAT REV and GAG are essential Nucleos |